ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $828,690 | -8.8% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $908,960 | -1.6% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $924,000 | -4.4% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $967,000 | +7.9% | 23,000 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $896,000 | -2.3% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $917,000 | +10.3% | 23,000 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $831,000 | -52.9% | 23,000 | -46.5% | 0.00% | -66.7% |
| Q2 2021 | $1,763,000 | -58.1% | 43,000 | -55.4% | 0.00% | -62.5% |
| Q1 2021 | $4,209,000 | -12.9% | 96,500 | 0.0% | 0.01% | -20.0% |
| Q4 2020 | $4,830,000 | +27.6% | 96,500 | +7.2% | 0.01% | +25.0% |
| Q3 2020 | $3,786,000 | +11.4% | 90,000 | +28.6% | 0.01% | 0.0% |
| Q2 2020 | $3,398,000 | – | 70,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |